- On-Track for First Patient Enrollment in 1Q 2020– - Company to Host R&D Symposium for Investors/Analysts on Tuesday January 14, 2020 in San Francisco, CA from 6:30 to 8:00 am (Pacific Time) - NEW YORK --(BUSINESS WIRE)--Jan. 13, 2020-- IVERIC bio, Inc.

- Featuring Zimura® Pivotal Program in Geographic Atrophy, Including the Design of the Second Pivotal Trial in GA - - Live Webcast to Begin at 6:30 a.m. Pacific Time - NEW YORK --(BUSINESS WIRE)--Dec. 19, 2019-- IVERIC bio, Inc. (Nasdaq: ISEE) today announced details for its R&D Investor Symposium

NEW YORK --(BUSINESS WIRE)--Dec. 19, 2019-- IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Glenn P. Sblendorio , Chief Executive Officer and President of IVERIC bio, will present an overview of the Company at the 38 th Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2020 at